WeVote

Bill

Bill

SB 387

Revises provisions relating to the prevention and early detection of lung cancer. (BDR 57-68)

2025 Regular Session Introduced by Roberta Lange

Nevada law updated to enhance lung cancer prevention and early detection measures through revised clinical and public health protocols.

Approved by the Governor. Chapter 208.
0
WeVote Research Nonpartisan
Bill Summary · SB 387

Legislative bill overview

SB 387 revises Nevada's lung cancer prevention and early detection provisions, though the specific substantive changes are not detailed in the bill summary provided. The legislation was introduced by Senator Roberta Lange and passed unanimously through both chambers before receiving gubernatorial approval in May 2025.

Why this is important

Lung cancer remains one of the leading causes of cancer-related deaths nationally and in Nevada. Early detection programs and prevention initiatives can significantly improve survival rates and treatment outcomes, potentially reducing healthcare costs and mortality. Any legislative updates to these frameworks reflect evolving medical evidence and public health priorities around screening accessibility and risk factor mitigation.

Potential points of contention

  • Screening criteria and access: Expansion of lung cancer screening eligibility could increase healthcare demand and costs, or conversely, restrictive criteria may limit access for at-risk populations
  • Implementation burden: Healthcare providers and insurers may face operational challenges or cost implications in implementing new detection protocols or prevention requirements
  • Funding mechanism: The bill does not clarify state funding sources for expanded prevention and screening programs, raising questions about fiscal sustainability

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.